Staar Surgical Co. said it expects to report first-quarter revenue of $14.8 million to $14.9 million, up 11 percent from the year-earlier period. That’s slightly below Wall Street expectations.

Staar makes implantable lens used to correct conditions such as myopia, cataracts, and glaucoma. Analysts surveyed by Thomson First Call were expecting $15 million of revenue for the quarter.

The Monrovia-based company, which plans release first quarter earnings after market close on May 1, said U.S. sales fell about 3 percent while international sales rose 20 percent.

Shares of Staar fell 12 cents, or 2 percent, to $5.33 in midday trading Monday on the Nasdaq.